BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2005

View Archived Issues

Glatiramer acetate reduces relapses more than beta interferons in multiple sclerosis

Read More

AZD-0530 inhibits osteoclast-mediated bone resorption in healthy volunteers

Read More

Lithium shows promise as anabolic bone therapy

Read More

Therapeutic benefits of melatonin in hemodialysis patients

Read More

SGN-35 shows potency in CD30+ malignancies in vitro; clinical trials to start shortly

Read More

20(S)-Protopanaxatriol exerts antitumor effects in lung cancer cells

Read More

CT-3: a novel synthetic cannabinoid for pain / News in Context

Read More

Novel tri-action somatostatin-dopamine agonists studied for control of GH secretion

Read More

FR-193262: a novel prostacyclin mimetic with oral bioavailability and antiaggregative effect

Read More

JYL-1421 is a potent TRPV1 antagonist in vitro and in vivo

Read More

PKCzeta --a novel target for asthma therapy

Read More

CJ-730: a novel matriptase inhibitor with antimetastatic properties

Read More

Marc Pharmaceuticals to investigate betulinol derivative for prostate cancer

Read More

Velcura receives SBIR for development of drugs for bone disorders

Read More

SR Pharma advances acquisition of Atugen

Read More

United Biomedical awarded NIH contract for therapeutic AIDS vaccine

Read More

Xenomics and Spallanzani sign definitive agreement for SpaXen joint venture

Read More

Corixa stockholder approval of merger with GlaxoSmithKline

Read More

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

Read More

SBIR grant supports development AV-101 for neuropathic pain

Read More

Xsira receives IND clearance for phase II study of adenosine for pain

Read More

MEND-CABG study of MC-1 completes enrollment

Read More

Hemosol selects IGIV as first therapeutic protein product for development

Read More

New agents for gastrointestinal disorders described in recent patent literature

Read More

New antibacterial transcription inhibitors emerge from French R&D

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 21, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing